| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Verve Therapeutics, Inc.
13G/A
VERV · 92539P101
|
0% |
7/28/2025
Event 7/25/2025
|
||||
| GV 2017, L.P. | 0% | |||||
| GV 2017 GP, L.P. | 0% | |||||
| GV 2017 GP, L.L.C. | 0% | |||||
| GV 2019, L.P. | 0% | |||||
| GV 2019 GP, L.P. | 0% | |||||
| GV 2019 GP, L.L.C. | 0% | |||||
| GV 2023, L.P. | 0% | |||||
| GV 2023 GP, L.P. | 0% | |||||
| GV 2023 GP, L.L.C. | 0% | |||||
| Alphabet Holdings LLC | 0% | |||||
| Verily Life Sciences LLC | 0% | |||||
| XXVI Holdings Inc. | 0% | |||||
| Alphabet Inc. | 0% | |||||
|
GitLab Inc.
13G/A
GTLB · 37637K108
|
4.3% |
2/13/2025
Event 12/31/2024
|
||||
| GV 2017, L.P. | 3.1% | |||||
| GV 2017 GP, L.P. | 3.1% | |||||
| GV 2017 GP, L.L.C. | 3.1% | |||||
| GV 2021, L.P. | 1.2% | |||||
| GV 2021 GP, L.P. | 1.2% | |||||
| GV 2021 GP, L.L.C. | 1.2% | |||||
| Alphabet Holdings LLC | 4.3% | |||||
| XXVI Holdings Inc. | 4.3% | |||||
| Alphabet Inc. | 4.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.